Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
October 29th 2019Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. A genetic screening project, LC-SCRUM, conducted by the National Cancer Center, is contributing to the development of multiple novel therapeutics in Japan. Live: Tuesday, Oct. 29, 2019 at 11am JST On demand available after airing until Oct. 29, 2020 Register free
Launch Strategies: Trends and Challenges for Biotech Companies
October 23rd 2019Michael Kleinrock, of The IQVIA Institute for Human Data Science, will moderate a panel of launch and market access experts, as they discuss how biotech companies have addressed some key challenges to achieve launch success. Specific points will include an assessment of the overall outlook, what makes launches excellent, how to determine your optimal strategy, and questions that need to be addressed when deciding whether to launch or to partner. Live: Wednesday, Oct. 23, 2019 at 10am EDT On demand available after airing until Oct. 23, 2020 Register free
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
October 15th 2019Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. A genetic screening project, LC-SCRUM, conducted by the National Cancer Center, is contributing to the development of multiple novel therapeutics in Japan. Live: Tuesday, Oct.15, 2019 at 5pm JST and Tuesday, Oct. 29, 2019 at 11am JST On demand available after airing until Oct.15, 2020 and Oct. 29, 2020 Register free